Natleo has built an impressive growth trajectory in a short period — revenue scaled from near-zero to ~$30K/month with a best-in-class 4.7 rating and #1 Ranking Juice. But growth is being constrained by three interrelated challenges: extremely high ad costs (ACOS ~140%, TACOS ~63%), weak organic positioning on the highest-volume keyword ("curcumin supplements" at rank 124), and conversion leakage on broad unbranded traffic. All three are fixable.
| Period | Revenue | Units | Orders | Ad Spend | Ad Sales |
|---|---|---|---|---|---|
| 2024 (May–Dec) | $16,237 | 996 | 812 | $18,195 | $8,134 |
| 2025 (Full Year) | $286,109 | 6,971 | 6,522 | $202,981 | $172,739 |
| 2026 Q1 (Jan–Mar) | $89,043 | 1,922 | 1,813 | $56,435 | $42,854 |
Revenue: +$54,156 (+155.2%) | Q1 2025: $34,887 → Q1 2026: $89,043
| Month | Revenue | Ad Spend | Ad Sales | TACOS | ACOS | Ad Sales % |
|---|---|---|---|---|---|---|
| Oct 2025 | $31,395 | $20,047 | $17,650 | 63.9% | 113.6% | 56.2% |
| Nov 2025 | $37,435 | $24,025 | $19,556 | 64.2% | 122.9% | 52.2% |
| Dec 2025 | $26,610 | $15,754 | $12,745 | 59.2% | 123.6% | 47.9% |
| Jan 2026 | $28,951 | $17,866 | $14,164 | 61.7% | 126.1% | 48.9% |
| Feb 2026 | $33,659 | $22,005 | $16,674 | 65.4% | 132.0% | 49.5% |
| Mar 2026 | $26,433 | $16,564 | $12,016 | 62.7% | 137.8% | 45.5% |
TACOS is running at 60–65% consistently, meaning for every $1 in revenue, $0.60–$0.65 is spent on advertising. ACOS is trending upward from 113% to 138% over the last 6 months. This is unsustainable and requires immediate intervention.
Positive signal: Ad Sales Share has trended down from ~78% in early 2025 to ~48% in Q1 2026 — organic traction is building, but TACOS at 60%+ remains unsustainable.
Natleo operates a single parent ASIN (B0DNGJXSKS) with two child variants. This is effectively a single-product brand on Amazon.
| Child ASIN | Product | Revenue | Rev % | Units | Sessions | CVR | ASP |
|---|---|---|---|---|---|---|---|
| B0DKPC8N3Y | 120 Count Hero | $42,221 | 73.4% | 844 | 4,122 | 20.48% | $50.03 |
| B0DKP88GTT | 60 Count | $15,303 | 26.6% | 427 | 3,519 | 12.13% | $35.84 |
The 120-count variant is the clear hero — 73.4% of revenue, strongest CVR (20.5%), and highest ASP ($50). The 60-count receives nearly equal sessions but converts at a much lower rate (12.1%), suggesting it may be cannibalizing traffic rather than serving a distinct customer segment.
The Theracurmin category has 7 relevant keywords (relevancy ≥30%, SV ≥350), representing ~54,719 in visible search volume.
| Keyword | Search Vol. | Relevancy | Natleo Rank | Best Competitor | Best Rank |
|---|---|---|---|---|---|
| theracurmin | 4,027 | 100% | 8 | Integrative Therapeutics | 1 |
| theracumin | 650 | 100% | 4 | Integrative Therapeutics | 1 |
| theracurmin curcumin | 574 | 89% | 7 | Natural Factors | 1 |
| curcumin supplements | 46,282 | 56% | 124 | Integrative Therapeutics | 23 |
| curcumin supplement | 1,667 | 56% | 39 | Integrative Therapeutics | 40 |
| cucuminin turmeric supps | 820 | 33% | 27 | Natural Factors | 29 |
| bioavailable curcumin | 699 | 33% | 30 | Integrative Therapeutics | 6 |
The single biggest organic opportunity is "curcumin supplements" — 46,282 search volume, but Natleo ranks at position 124. This keyword alone represents 85% of all relevant search volume. Cracking Page 1 here would fundamentally change the economics of this account.
| Search Query | SQV | ASIN CTR | Mkt CTR | ASIN CVR | Mkt CVR | Price Δ |
|---|---|---|---|---|---|---|
| natleo curcumin | 122 | 19.28% | 1.99% | 41.43% | 39.76% | $0 |
| natleo max strength curcumin | 86 | 21.16% | 2.29% | 39.22% | 32.81% | $0 |
| okinawa turmeric curcumin | 2,120 | 2.36% | 1.09% | 21.74% | 7.44% | +$30.50 |
| okinawa turmeric | 4,160 | 1.45% | 1.16% | 22.22% | 5.69% | +$14.50 |
| theracurmin 300mg | 56 | 5.06% | 1.66% | 33.33% | 26.67% | +$22.00 |
| theracurmin turmeric curcumin | 71 | 6.22% | 1.16% | 23.08% | 21.88% | $0 |
| curcusorb theralogix | 74 | 3.01% | 1.95% | 40.00% | 20.00% | -$16.00 |
On several Bucket D terms, Natleo is converting at 2–4x the market rate while pricing at a premium (+$14–$30). This is remarkable — it demonstrates genuine product-market fit on Theracurmin-specific and okinawa-related queries.
| Search Query | SQV | ASIN CTR | Mkt CTR | CTR Δ | ASIN CVR | Mkt CVR | CVR Δ |
|---|---|---|---|---|---|---|---|
| curcumin | 159,073 | 2.22% | 1.89% | +0.33% | 9.93% | 17.54% | -7.61% |
| theracurmin | 11,131 | 2.73% | 1.87% | +0.87% | 9.27% | 12.96% | -3.69% |
| theracumin | 1,574 | 2.61% | 1.46% | +1.15% | 8.99% | 14.34% | -5.35% |
| theracurmin supplements | 1,057 | 2.45% | 1.97% | +0.48% | 10.34% | 16.02% | -5.68% |
| theracurmin curcumin | 900 | 2.42% | 1.79% | +0.63% | 10.71% | 19.16% | -8.44% |
| liposomal curcumin | 8,525 | 2.08% | 2.00% | +0.08% | 7.41% | 11.24% | -3.84% |
| best turmeric supp. for inflammation | 2,715 | 3.16% | 1.86% | +1.31% | 6.45% | 15.66% | -9.21% |
| curcumin natleo | 16 | 21.43% | 1.75% | +19.67% | 58.33% | 58.33% | 0.00% |
| natleo | 18 | 28.57% | 8.93% | +19.64% | 20.00% | 20.00% | 0.00% |
On "curcumin" (159K SQV), we win more clicks than the market (+0.33% CTR) but trail on conversion by 7.6%. This is the largest volume term where our listing persuasion is falling short. A stronger "Standard Curcumin vs Theracurmin" comparison image would be the single most impactful addition for closing this gap.
| Search Query | SQV | ASIN CTR | Mkt CTR | CTR Δ | ASIN CVR | Mkt CVR | CVR Δ |
|---|---|---|---|---|---|---|---|
| cucurmin supplements | 4,834 | 0.52% | 1.27% | -0.76% | 20.00% | 18.53% | +1.47% |
| curvumin supplement | 2,316 | 1.51% | 1.79% | -0.28% | 28.57% | 16.93% | +11.64% |
| bioavailable curcumin | 1,645 | 1.98% | 2.13% | -0.15% | 16.67% | 10.98% | +5.69% |
| theracurcumin | 260 | 0.86% | 1.68% | -0.81% | 40.00% | 15.38% | +24.62% |
These terms convert at up to 2.5x the market rate once shoppers reach our listing, but we're not winning enough clicks in search results. This points to a main image, title, or search-result appeal issue. A main image A/B test and improved search snippet can unlock significant additional volume here.
| Search Query | SQV | ASIN CTR | Mkt CTR | CTR Δ | ASIN CVR | Mkt CVR | CVR Δ |
|---|---|---|---|---|---|---|---|
| curcumin supplements | 85,431 | 1.55% | 2.01% | -0.46% | 11.06% | 17.27% | -6.21% |
| turmeric supplement | 583,748 | 1.43% | 2.06% | -0.63% | 7.69% | 25.62% | -17.93% |
| turmeric curcumin supplement | 504,288 | 1.22% | 2.08% | -0.86% | 24.49% | 25.89% | -1.40% |
| curamin | 7,335 | 0.65% | 1.99% | -1.34% | 6.67% | 23.80% | -17.14% |
| circumin supplement | 6,862 | 1.23% | 1.88% | -0.65% | 14.81% | 20.18% | -5.37% |
| curamin extra strength 120 | 5,013 | 1.53% | 2.23% | -0.71% | 11.19% | 27.66% | -16.47% |
| terry naturally curamin extra strength | 4,514 | 0.88% | 1.85% | -0.97% | 5.56% | 19.67% | -14.11% |
| theracurmin hp by integ. therapeutics | 2,574 | 1.25% | 1.79% | -0.53% | 10.94% | 36.77% | -25.84% |
Two important patterns: (1) Competitor brand terms (curamin, terry naturally, theracurmin HP) show deep CVR deficits of -14% to -26% — shoppers searching for these specific brands rarely switch. (2) Broad generic terms (turmeric supplement, curcumin supplements) have massive volume but we underperform on both CTR and CVR. Reduce spend here and invest in Bucket D winners instead.
| Search Term | Spend | Sales | ACOS | CVR | Signal |
|---|---|---|---|---|---|
| natleo curcumin | $49 | $573 | 8.6% | 42.9% | Scale |
| natleo max strength curcumin | $47 | $654 | 7.2% | 71.4% | Scale |
| okinawa turmeric curcumin | $111 | $316 | 35.1% | 28.6% | Scale |
| bioavailable curcumin | $53 | $88 | 59.7% | 22.2% | Increase spend |
| cucurmin supplements | $54 | $124 | 43.8% | 23.1% | Increase spend |
| okinawa turmeric | $24 | $52 | 46.7% | 25.0% | Scale |
| theracurmin 300mg | $29 | $52 | 55.1% | 33.3% | Scale |
| Search Term | Spend | Sales | ACOS | CVR | Signal |
|---|---|---|---|---|---|
| curcumin | $10,588 | $5,050 | 209.7% | 8.6% | Reduce bids |
| theracurmin | $5,258 | $5,099 | 103.1% | 18.0% | Optimize |
| curcumin supplements | $1,591 | $945 | 168.4% | 7.6% | Fix CVR first |
| turmeric curcumin supplement | $1,553 | $1,405 | 110.6% | 7.5% | Optimize |
| curamin extra strength | $649 | $729 | 89.0% | 13.1% | Monitor |
| turmeric supplement | $603 | $560 | 107.7% | 7.5% | Optimize |
"Curcumin" alone = $10,588 at 210% ACOS (28% of all ad spend). Meanwhile, Bucket D winners get less than $300 combined. Our branded terms (natleo curcumin, natleo max strength) are extremely efficient at 7–9% ACOS but severely underleveraged. Massive reallocation opportunity.
Cross-referencing the 7 keywords from the ranking analysis with their ad performance:
| Keyword | Org. Rank | Ad Spend | Ad Sales | ACOS | CVR | Assessment |
|---|---|---|---|---|---|---|
| theracurmin | 8 | $5,258 | $5,099 | 103% | 18.0% | Near target — optimize bids |
| theracumin | 4 | $7 | $0 | N/A | 0.0% | Minimal exposure |
| theracurmin curcumin | 7 | $536 | $285 | 188% | 13.5% | Inefficient — reduce bids |
| curcumin supplements | 124 | $1,591 | $945 | 168% | 7.6% | Major gap — fix CVR first |
| curcumin supplement | 39 | $62 | $52 | 120% | 9.1% | Near target — low spend |
| cucuminin turmeric supps | 27 | $18 | $0 | N/A | 0.0% | Minimal data |
| bioavailable curcumin | 30 | $53 | $88 | 60% | 22.2% | Efficient — increase spend |
The data reveals a clear pattern: our best organic ranks (theracurmin at #4–#8) align with our best ad efficiency. But our biggest ranking gap ("curcumin supplements" at #124) also has our worst ad ACOS (168%). Fix listing conversion first, then use efficient ad presence to support the organic climb.
| Ad Type | Spend | Sales | Orders | ACOS | Share |
|---|---|---|---|---|---|
| Sponsored Products | $31,051 | $21,555 | 474 | 144.1% | 83.4% |
| Sponsored Brands | $6,196 | $5,134 | 101 | 120.7% | 16.6% |
| Sponsored Display | — | — | — | — | 0% |
| Total | $37,247 | $26,688 | 575 | 139.6% | 100% |
| Campaign | Spend | Sales | Orders | ACOS |
|---|---|---|---|---|
| SB Video — B0DKPC8N3Y (Exact KW) | $4,173 | $3,712 | 72 | 112.4% |
| SB Video — B0DKP88GTT (Broad KW) | $1,652 | $1,142 | 23 | 144.7% |
| SB Headline — Keyword Broad | $371 | $280 | 6 | 132.5% |
| Match Type | Spend | Sales | Orders | ACOS | CPC | CVR | RPC |
|---|---|---|---|---|---|---|---|
| Exact | $14,725 | $9,442 | 209 | 156.0% | $7.99 | 11.3% | $5.12 |
| Broad | $10,893 | $7,728 | 159 | 141.0% | $7.21 | 10.5% | $5.12 |
| Auto | $5,354 | $4,385 | 106 | 122.1% | $4.23 | 8.4% | $3.47 |
| Phrase | $79 | $0 | 0 | N/A | $7.20 | 0% | $0.00 |
Exact match is the highest spend and worst ACOS (156%), driven primarily by expensive CPCs ($7.99). Auto campaigns are actually the most efficient at 122% ACOS. CPC of $7–$8 on exact match is unsustainable — RPC-based bidding would cap CPCs at $5.12 (the actual revenue per click).
| Tier | Ad Spend | Spend % | Sales | Orders | Avg CPC | Avg RPC |
|---|---|---|---|---|---|---|
| >120% ACOS | $27,586 | 74.1% | $16,907 | 375 | $6.26 | $3.83 |
| 80–120% ACOS | $6,120 | 16.4% | $5,835 | 120 | $5.60 | $5.34 |
| <80% ACOS | $2,040 | 5.5% | $3,946 | 80 | $4.25 | $8.22 |
| High Spend, No Orders | $596 | 1.6% | $0 | 0 | $3.26 | $0.00 |
| Low Spend, No Orders | $904 | 2.4% | $0 | 0 | $3.93 | $0.00 |
74% of all ad spend ($27,586) sits in the >120% ACOS tier, where average CPC ($6.26) exceeds RPC ($3.83) by 63%. Only 5.5% of spend is in the profitable <80% ACOS tier. Account AOV is $47.90 with a blended CVR of 16.6%. By applying RPC-based bid caps and reallocating from the >120% tier into proven winners, we can maintain sales while dramatically cutting waste.
| Search Term | Spend | Sales | Orders | CVR | ACOS |
|---|---|---|---|---|---|
| curcumin | $8,664 | $3,708 | 86 | 8.2% | 233.7% |
| theracurmin (Exact) | $2,351 | $2,060 | 44 | 20.3% | 114.1% |
| theracurmin (Broad) | $1,735 | $1,424 | 26 | 16.0% | 121.9% |
| curcumin supplements | $607 | $489 | 10 | 9.3% | 124.1% |
| theracurmin (SBV) | $612 | $817 | 17 | 20.5% | 74.9% |
| curamin extra strength | $440 | $452 | 9 | 13.8% | 97.3% |
| ASIN B0797FSF89 | $426 | $323 | 9 | 9.6% | 131.9% |
| ASIN B01D8V075U | $421 | $405 | 9 | 9.7% | 103.9% |
| curcumin (Broad) | $377 | $160 | 4 | 8.0% | 235.9% |
| theracurmin supplements | $369 | $245 | 5 | 14.7% | 150.8% |
The term "curcumin" accounts for $10,588 in combined SP+SB spend at 210% ACOS. This single term is consuming 28% of the total ad budget while returning only 47 cents for every dollar spent. Meanwhile, Bucket D winners (our best performers) receive less than $300 combined. Massive reallocation opportunity.
| Placement | Spend | Sales | ACOS | CPC | CVR | RPC |
|---|---|---|---|---|---|---|
| Top of Search | $15,463 | $11,539 | 134.0% | $8.03 | 13.3% | $5.99 |
| Rest of Search | $9,101 | $6,565 | 138.6% | $5.41 | 8.6% | $3.90 |
| Product Pages | $6,481 | $3,399 | 190.7% | $6.35 | 7.1% | $3.33 |
Top of Search is the best-performing placement with the highest CVR (13.3%) and best ACOS (134%). Product Pages is the worst at 191% ACOS. Increase Top of Search bid adjustments selectively on proven converting terms, and reduce or cap Product Pages placement.
The orange palette is memorable, category-relevant (turmeric), and gives the stack cohesive identity. More retail energy than clinical competitors in the space.
Shoppers can quickly grasp this is a turmeric/curcumin product with Theracurmin and a bioavailability advantage.
Images with turmeric powder, roots, and capsules make the product feel intuitive.
Current main image includes box, bottle, and loose capsules — creates presence but feels crowded. Packaging hierarchy is confusing (box emphasizes Theracurmin, bottle emphasizes Curcumin). At thumbnail size, this weakens clarity.
"43x more bioavailable" claim needs stronger visual support: clean scientific explainer graphic, study-backed comparison visuals, side-by-side ingredient logic.
Several slides feel more like competent marketplace graphics than brand-building premium creative. Heavy reliance on text blocks and stock-style wellness visuals.
Trust points (gluten free, natural, no additives, bottled in USA) present but lack deeper proof signals like manufacturing credibility, testing language, and substantiated feature comparisons.
A strong "Standard Curcumin vs Theracurmin" comparison slide would be the single most impactful addition for conversion improvement.
High Priority| Brand | ASIN | Price | Rating | Reviews | Listing Age |
|---|---|---|---|---|---|
| Natleo USA (Us) | B0DKPC8N3Y | $51.99 | 4.7 | 221 | 1 yr, 6 mos |
| Integrative Therapeutics | B00UZE9YZI | $56.00 | 4.6 | 2,638 | 11 yrs, 1 mo |
| Integrative Therapeutics | B0765DHTVL | $93.50 | 4.6 | 2,638 | 8 yrs, 6 mos |
| Natural Factors | B00CJ71JCK | $38.47 | 4.6 | 1,829 | 9 yrs, 11 mos |
| Natural Factors | B007Q7MU0S | $20.97 | 4.6 | 1,829 | 12 yrs, 12 mos |
| Natural Factors | B07BSMKPY5 | $67.17 | 4.6 | 1,431 | 8 yrs, 1 mo |
| TRU NIAGEN | B09RYW9VSB | $29.85 | 4.5 | 417 | 4 yrs, 1 mo |
| IMMUNOVITES | B07M9CZ85T | $29.99 | 4.5 | 187 | 6 yrs, 7 mos |
| Pure Encapsulations | B0FRST29QX | $70.00 | 4.6 | 23 | 5 mos |
Our rating (4.7) is the highest in the competitive set — a genuine advantage. However, our review count (221) is significantly below the market median (1,431). Given we're only 1.5 years old vs a median of nearly 3 years, the gap is understandable but impacts shopper trust on broad terms where buyers compare multiple options.
| Rank | Brand (ASIN) | Overall Score | Title | Bullets | Description |
|---|---|---|---|---|---|
| #1 | Natleo (B0DKPC8N3Y) | 114,792 | 10/10 | 7/10 | 1/10 |
| #2 | Natural Factors (B007Q7MU0S) | 80,725 | 10/10 | 7/10 | 1/10 |
| #3 | Natural Factors (B07BSMKPY5) | 80,725 | 10/10 | 7/10 | 1/10 |
| #4 | TRU NIAGEN (B09RYW9VSB) | 44,460 | 10/10 | 7/10 | 1/10 |
| #5 | Integrative Therapeutics (B00UZE9YZI) | 34,433 | 10/10 | 7/10 | 1/10 |
Natleo leads the entire competitive set with a Ranking Juice score of 114,792 — 42% higher than the #2 competitor. This is a significant structural advantage that, combined with conversion improvements, should accelerate organic rank gains.
Natleo USA Supplements has built an impressive growth trajectory in a relatively short period. Revenue has scaled from near-zero in late 2024 to ~$30K/month, and Q1 2026 revenue ($89K) is 2.5x Q1 2025. The product has a best-in-class rating (4.7), category-leading Ranking Juice, and strong conversion rates on high-intent Theracurmin queries.
However, the account is currently constrained by three interrelated challenges:
ACOS ~140%, TACOS ~63%. We are spending significantly more on ads than we earn back directly from those ads.
"Curcumin supplements" at rank 124 forces us to buy visibility through ads — the #1 volume keyword at 46K SV.
SQP shows we win clicks but trail market CVR on key terms, pointing to PDP persuasion gaps on cold traffic.
74% of spend is in the >120% ACOS tier. By reducing bids on poor performers (especially "curcumin" at 234% ACOS), cutting no-order targets, and reallocating to proven winners, we can materially improve ACOS without sacrificing growth.
CriticalThe SQP Bucket B gap is the biggest commercial opportunity. Redesigning the image stack to include a strong "Standard Curcumin vs Theracurmin" comparison, better trust architecture, and clearer benefit hierarchy will lift CVR across all traffic sources.
High ImpactTerms like "okinawa turmeric curcumin" (SV 2,120) and "okinawa turmeric" (SV 4,160) show we beat market on both CTR and CVR at premium pricing. Ideal for single-keyword campaigns and ranking investment.
Quick WinThis 46K SV keyword is the biggest unlock for reducing ad dependency. Requires a combination of conversion improvement, sustained ad presence, and potentially promotional velocity.
StrategicOur CVR trails market by 7.6% on "curcumin" — fixing this through PDP optimization is non-negotiable for sustainable growth.
Average CPC of $7–$8 on exact match is too high relative to current conversion rates. RPC-based bidding would bring CPCs in line with actual returns.
221 reviews vs median 1,431 creates a trust gap, especially on broad category terms where shoppers compare multiple options.
With a 20% CVR, 80% of visitors leave without purchasing. Sponsored Display retargeting could recapture these shoppers efficiently.
For a daily supplement, Subscribe & Save should be a core growth lever. Recommended approach:
10–15% SnS discount on first purchase to drive enrollment | SnS-focused messaging in image stack ("Daily Turmeric Routine" / "Never Run Out") | SnS-targeted advertising on branded and high-intent exact keywords.
Cleaner hero composition with stronger product focus, better depth/lighting, and resolved packaging hierarchy.
The single most impactful creative addition for conversion lift. Should include clean scientific explainer and study-backed comparison visuals.
Rebuild the trust-badge slide with manufacturing credibility, testing language, and premium quality signals.
While Ranking Juice is already #1, test title variations that emphasize the highest-converting keyword patterns from SQP data.